{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T23:10:21Z","timestamp":1769382621799,"version":"3.49.0"},"reference-count":77,"publisher":"Baishideng Publishing Group Inc.","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i29.6573","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T12:33:27Z","timestamp":1469795607000},"page":"6573","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance"],"prefix":"10.3748","volume":"22","author":[{"given":"Miguel","family":"Jim\u00e9nez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Gonz\u00e1lez-Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Espa\u00f1a Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Pinazo Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"de la Cruz Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Olmedo Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27950"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i4.1421"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03430.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/v7112902"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/v7112902"},{"key":"ref7","unstructured":"Bacon B, Dieterich D, Flamm S, Kowdley K, Lawitz E, Milligan S, Younossi Z Naoky Tsai. Efficacy of sofosbuvir and simeprevir-based regimens for 304 HCV treatment experienced patients in a reallife setting; data from the TRIO network. [Abstract 975] 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Nov 7-11, 2014; Boston, MA. Hepatology 2014;60 Suppl 1:S672."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30978-8"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30014-3"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30980-6"},{"key":"ref11","unstructured":"Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, Morelli G, Feld J, Brown RS, Frazier LM. Safety and efficacy of sofosbuvir (SOF) in combination with simeprevir (SIM) ribavirin (RBV) in patients with genotype 1: interim results of a prospective, observational study. [Abstract 955] 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Nov 7-11, 2014; Boston, MA. Hepatology 2014;60 Suppl 1:S660."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30149-5"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30162-8"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30186-0"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.08.010"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02716.x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.055"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.09.011"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27053"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27934"},{"key":"ref21","unstructured":"Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. Fields Virology. 5th Edition Philadelphia: Lippincott-Raven Publishers; 2012;1101-1152."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-394-3_4"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Martell M, Esteban JI, Quer J, Genescà J, Weiner A, Esteban R, Guardia J, Gómez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-3229.","DOI":"10.1128\/jvi.66.5.3225-3229.1992"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.175018"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro16457"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2012.11.005"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5424.110"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-005X(13)70113-7"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24262"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00065-"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000544"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Herrmann E, Neumann AU, Schmidt JM, Zeuzem S. Hepatitis C virus kinetics. Antivir Ther 2000;5:85-90.","DOI":"10.1177\/135965350000500203"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1105797108"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010952"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01217-10"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn175"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01598-08"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.043"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i12.3480"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02778-12"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu696"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.10.001"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis761"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.01.003"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit226"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.032"},{"key":"ref47","unstructured":"Yeh WW, Lipardi C, Jumes P, De Lepeleire IM, Van den Bulk N, Caro L, Huang X, Mangin E, Nachbar RB, Gane EJ. MK-8742, a HCV NS5A inhibitor with a broad spectrum of HCV genotypic activity, demonstrates potent antiviral activity in genotype-1 and -3 HCV infected patients. [Abstract 479] 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Nov 1-5, 2013; Washington DC. Hepatology 2013;58 Suppl 1:438a-439a."},{"key":"ref48","unstructured":"Lahser F, Liu R, Bystol K, Xia E, Raubertas R, Asante-Appiah E. A combination containing MK-5172 (HCV NS3 protease inhibitor) and MK-8742 (HCV NS5A inhibitor) demonstrates high barrier to resistance in HCV replicons. [Abstract 87] 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Nov 9-13, 2012; Boston, MA. Hepatology 2012;56:236a."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.06.014"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i11.2902"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30071-4"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.08.015"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(11)61244-0"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26388"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12091"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00054-12"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit562"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.12.012"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12405"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu697"},{"key":"ref65","unstructured":"Krishnan P, Tripathi R, Schnell G, Reisch T, Beyer J, Irvin M, Xie W, Larsen L, Podsadecki T, Pilot-Matias T. Pooled analysis of resistance in patients treated with ombitasvir\/ABT-450\/r and dasabuvir with or without ribavirin in Phase 2 and Phase 3 clinical trials. [Abstract 1936] 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Nov 7-11, 2014; Boston, MA. Hepatology 2014;60 Suppl 1:1134a-1135a."},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04619-14"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2012.09.011"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105569"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-355"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.04.024"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu613"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-015-2563-3"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60494-3"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60538-9"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.041"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24255"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i29\/6573.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T07:51:19Z","timestamp":1656921079000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i29\/6573.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":77,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i29.6573","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}